Advertisement
Advertisement
HRTX
Heron Therapeutics, Inc.
0.37
USDSponsored
0.00
+0.94%
Nov 10, 15:59 UTC -5
Closed
After-Market
0.37
0.00
-0.29%
Heron Therapeutics, Inc. (HRTX)
Heron Therapeutics, Inc. Financial Snapshot
| Market Cap | 70.81M |
| Beta | 1.65 |
| Earnings Per Share (EPS) | -0.19 |
| Price-to-Book (P/B) Ratio | 9.65 |
| Operating Margin | -16.60% |
| Total Debt/Equity (D/E) | 2065.00% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -293.02% |
| Current Ratio | 2.49% |
| Free Cash Flow | -4.28M |
